0001562180-24-001290.txt : 20240213
0001562180-24-001290.hdr.sgml : 20240213
20240213173759
ACCESSION NUMBER: 0001562180-24-001290
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240209
FILED AS OF DATE: 20240213
DATE AS OF CHANGE: 20240213
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Duker Jay S.
CENTRAL INDEX KEY: 0001630864
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51122
FILM NUMBER: 24630379
MAIL ADDRESS:
STREET 1: C/O ELEVEN BIOTHERAPEUTICS
STREET 2: 215 1ST ST. #400
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EyePoint Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001314102
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 262774444
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 480 PLEASANT STREET
STREET 2: SUITE B300
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 617-926-5000
MAIL ADDRESS:
STREET 1: 480 PLEASANT STREET
STREET 2: SUITE B300
CITY: WATERTOWN
STATE: MA
ZIP: 02472
FORMER COMPANY:
FORMER CONFORMED NAME: pSivida Corp.
DATE OF NAME CHANGE: 20080619
FORMER COMPANY:
FORMER CONFORMED NAME: pSivida LTD
DATE OF NAME CHANGE: 20050111
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0508
4
2024-02-09
false
0001314102
EyePoint Pharmaceuticals, Inc.
EYPT
0001630864
Duker Jay S.
C/O EYEPOINT PHARMACEUTICALS, INC.
480 PLEASANT STREET
WATERTOWN
MA
02472
true
true
false
false
President and CEO
false
Common Stock
2024-02-09
4
M
false
7000.00
0.00
A
50486.00
D
Common Stock
2024-02-09
4
M
false
4967.00
0.00
A
55453.00
D
Common Stock
2024-02-09
4
F
false
2075.00
28.80
D
53378.00
D
Common Stock
2024-02-09
4
F
false
1458.00
28.80
D
51920.00
D
Restricted Stock Units
0.00
2024-02-09
4
M
false
4967.00
0.00
D
2031-02-09
Common Stock
4967.00
0.00
D
Restricted Stock Units
0.00
2024-02-09
4
M
false
7000.00
0.00
D
2032-02-09
Common Stock
7000.00
7000.00
D
No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units
The restricted stock units will vest in three ratable annual installments beginning February 9, 2022.
The restricted stock units will vest in three ratable annual installments beginning February 9, 2023.
/s/ Ron Honig, Attorney-in-Fact
2024-02-13